FibroBiologics, Inc. 8K

FibroBiologics, Inc. appointed Leigh Steinberg to its Board of Directors to leverage his extensive dealmaking experience and advocacy in human longevity and brain health in support of the company’s fibroblast-based therapeutic programs.

FibroBiologics, Inc. announced that it has appointed Leigh Steinberg, a prominent sports agent and long-time advocate for human longevity and brain health, to its Board of Directors. Steinberg, currently CEO of Steinberg Sports & Entertainment, brings more than five decades of dealmaking experience, extensive relationships across sports, medicine, business, and media, and a track record of initiatives in chronic disease and neurological health. Company CEO and Chairman Pete O'Heeron highlighted Steinberg’s negotiating skills and influential network as valuable assets to support FibroBiologics’ fibroblast-based therapeutic pipeline, including its human longevity program, while Steinberg expressed his commitment to leveraging his experience and relationships to advance the company’s mission in chronic disease and longevity.

Filing Facts

CIK

1958777

Ticker

-

Form

8K

Source Type

sec

Accession

0001193125-26-362027

Alert Tier

5